Cathie Wood
ONC

Cathie Wood’s BeOne Medicines Ltd ONC Stock Holding History

Cathie Wood’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-20,207
Closed -$3.48M – 202
2018
Q3 		$3.48M Buy
+20,207
New +$3.4M 0.11% 79

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Cathie Wood's ONC Position: Q4 2018 in Review

Cathie Wood sold out of BeOne Medicines Ltd (ONC) in Q4 2018, closing a stake of 20,207 shares — an estimated $3.48M sold.

Cathie Wood first reported a position in ONC in Q3 2018 and held it in 1 quarter. The position peaked at $3.48M in Q3 2018. 192 funds tracked by Wall St. Rank hold ONC as of Q4 2018.

  • Cathie Wood reported no remaining BeOne Medicines Ltd position as of Q4 2018 after selling out during the quarter.
  • Cathie Wood sold 20,207 BeOne Medicines Ltd shares in Q4 2018, an estimated $3.48M.
  • Cathie Wood first reported a position in BeOne Medicines Ltd in Q3 2018 and held it in 1 quarter.
  • Cathie Wood's BeOne Medicines Ltd position peaked at $3.48M in Q3 2018.
  • 192 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2018.

Based on ARK Investment Management's 13F filing for Q4 2018, filed 1 Feb 2019.